Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMMX Immix Biopharma, Inc

未开盘 11-18 16:00:00 EST

1.69

+0.10

+6.29%

盘后1.69

+0.000.00%

18:02 EST

最高1.80	最低1.58	成交量11.33万
今开1.58	昨收1.59	日振幅13.84%
总市值4,649万	流通市值2,694万	总股本2,751万
成交额19.17万	换手率0.71%	流通股本1,594万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMMX","market":"US","secType":"STK","nameCN":"Immix Biopharma, Inc","latestPrice":1.69,"timestamp":1731963600000,"preClose":1.59,"halted":0,"volume":113343,"hourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.69,"latestTime":"18:02 EST","volume":25,"amount":44.25,"timestamp":1731970954501},"delay":0,"floatShares":15940719,"shares":27507637,"eps":-0.831087,"marketStatus":"未开盘","marketStatusCode":0,"change":0.1,"latestTime":"11-18 16:00:00 EST","open":1.58,"high":1.8,"low":1.58,"amount":191699.554783,"amplitude":0.138365,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.831087,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1639630800000,"adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.59,"preClose":1.59,"latestTime":"09:28 EST","volume":300,"amount":478.00001999999995,"timestamp":1731940080026},"postHourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.69,"latestTime":"18:02 EST","volume":25,"amount":44.25,"timestamp":1731970954501},"volumeRatio":2.172046,"impliedVol":0.5532,"impliedVolPercentile":0.0721},"requestUrl":"/m/hq/s/IMMX/tweets","defaultTab":"tweets","newsList":[{"id":"2484672103","title":"Immix Biopharma, Inc.盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672103?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:45","pubTimestamp":1731944715,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时45分，Immix Biopharma, Inc.股票出现异动，股价大幅上涨5.03%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为685.77%、559.45%、435.12%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为217.24%、75.18%、73.24%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823451598e434a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823451598e434a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2483387037","title":"Immix Biopharma, Inc.盘中异动 急速拉升5.10%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483387037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483387037?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:47","pubTimestamp":1731606443,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时47分，Immix Biopharma, Inc.股票出现波动，股价大幅拉升5.10%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、奥麦罗制药涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为3789.93%、3243.61%、373.16%，振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为249.67%、112.92%、106.82%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115014723abc1c8f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115014723abc1c8f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2483833863","title":"Immix 生物制药公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833863","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833863?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:53","pubTimestamp":1731513234,"startTime":"0","endTime":"0","summary":"Immix 生物制药公司公布截至 9 月 30 日的季度业绩 - 收益摘要Immix Biopharma Inc IMMX.OQ报告，截至9月30日的季度调整后每股亏损24美分，低于去年同期的每股-23美分。Immix Biopharma Inc 公布的本季度每股收益为亏损 24 美分。该公司当季亏损 715 万美元。Immix Biopharma Inc 本季度股价上涨了 15.4%，今年迄今为止亏损了 75.1%。华尔街对 Immix Biopharma Inc 的 12 个月目标价中位数为 7.00 本摘要由 LSEG 数据于 11 月 13 日 03:53 p.m. UTC 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4T3MK1QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2483058833","title":"Immix Biopharma, Inc.盘中异动 大幅下跌6.98%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483058833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483058833?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:46","pubTimestamp":1731512784,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时46分，Immix Biopharma, Inc.股票出现异动，股价大幅下挫6.98%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为455.54%、262.95%、95.85%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Lexeo Therapeutics, Inc.，振幅分别为84.00%、46.01%、44.21%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111323462498e42689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111323462498e42689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2482759290","title":"Immix Biopharma, Inc.盘中异动 急速下挫5.74%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482759290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482759290?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:32","pubTimestamp":1731349961,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时32分，Immix Biopharma, Inc.股票出现异动，股价快速下挫5.74%。截至发稿，该股报1.75美元/股，成交量5.0264万股，换手率0.18%，振幅8.06%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202324198e41ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202324198e41ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2481152815","title":"Immix Biopharma Inc  预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481152815","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481152815?lang=zh_cn&edition=full","pubTime":"2024-11-08 05:15","pubTimestamp":1731014100,"startTime":"0","endTime":"0","summary":"Immix Biopharma Inc  预计每股亏损 16 美分 - 财报前瞻Immix Biopharma Inc IMMX.OQ IMMX.O预计在11月9日公布截至2024年9月30日的业绩时，季度收入将不会有任何变化() LSEG的分析师平均预计Immix Biopharma Inc每股亏损16美分。华尔街对 Immix Biopharma Inc 的 12 个月目标价中位数为 7.00 美元，高于其上一次收盘价 1.60 美元。11月7日 - 本摘要于北京时间 11 月 7 日 21:14 机器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME2TR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX"],"gpt_icon":0},{"id":"2481685674","title":"Immix Biopharma, Inc.盘中异动 股价大跌6.33%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481685674?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:09","pubTimestamp":1730819367,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日23时09分，Immix Biopharma, Inc.股票出现波动，股价快速下挫6.33%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃，换手率分别为4788.33%、1547.41%、549.55%，振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Psyence Biomedical Ltd.，振幅分别为67.30%、42.31%、29.44%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230927971a474b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230927971a474b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2478484218","title":"Immix Biopharma, Inc.盘中异动 快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478484218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478484218?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:23","pubTimestamp":1730125398,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时23分，Immix Biopharma, Inc.股票出现异动，股价快速拉升5.42%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Eyepoint Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为629.62%、53.92%、52.34%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822231898e3ed97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822231898e3ed97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2478966282","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478966282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478966282?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:45","pubTimestamp":1729885504,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时45分，Immix Biopharma, Inc.股票出现波动，股价大幅上涨5.03%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为872.75%、795.56%、442.54%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026034504ab74a472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026034504ab74a472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2477864860","title":"Immix Biopharma, Inc.盘中异动 快速跳水5.20%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477864860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477864860?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:45","pubTimestamp":1729521915,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时45分，Immix Biopharma, Inc.股票出现波动，股价大幅跳水5.20%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为4809.75%、2606.04%、1125.81%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.，振幅分别为263.20%、157.02%、118.79%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021224516a1e24d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021224516a1e24d4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2476204451","title":"Immix Biopharma, Inc.盘中异动 股价大涨6.94%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476204451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476204451?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:33","pubTimestamp":1729172006,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时33分，Immix Biopharma, Inc.股票出现异动，股价快速上涨6.94%。截至发稿，该股报1.54美元/股，成交量2.3484万股，换手率0.09%，振幅2.78%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213326971a0d51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213326971a0d51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2475654231","title":"Immix Biopharma, Inc.盘中异动 快速拉升6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475654231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475654231?lang=zh_cn&edition=full","pubTime":"2024-10-16 01:53","pubTimestamp":1729014816,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日01时53分，Immix Biopharma, Inc.股票出现波动，股价急速上涨6.52%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Bright Minds Biosciences Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为1856.77%、465.60%、344.63%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为1126.10%、173.40%、123.44%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016015336ab6a4d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016015336ab6a4d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2474094542","title":"Immix Biopharma, Inc.盘中异动 早盘快速拉升6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474094542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474094542?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:30","pubTimestamp":1728653443,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时30分，Immix Biopharma, Inc.股票出现波动，股价大幅上涨6.01%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为85.51%、37.28%、10.62%，振幅较大的相关个股有Immix Biopharma, Inc.、Protagenic Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为7.46%、7.45%、5.37%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112130449719fa85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112130449719fa85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2474740020","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.84%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474740020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474740020?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:58","pubTimestamp":1728572301,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时58分，Immix Biopharma, Inc.股票出现异动，股价急速下挫5.84%。截至发稿，该股报1.45美元/股，成交量1.178万股，换手率0.04%，振幅5.19%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010225821ab692c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010225821ab692c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2474481224","title":"Immix Biopharma, Inc.盘中异动 早盘股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474481224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474481224?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:23","pubTimestamp":1728483783,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时23分，Immix Biopharma, Inc.股票出现异动，股价快速跳水5.88%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为664.54%、326.03%、166.11%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.，振幅分别为108.00%、45.37%、39.02%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100922230398e3b7ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100922230398e3b7ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2473262478","title":"Immix Biopharma, Inc.盘中异动 股价大涨6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473262478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473262478?lang=zh_cn&edition=full","pubTime":"2024-10-08 21:39","pubTimestamp":1728394789,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日21时39分，Immix Biopharma, Inc.股票出现波动，股价大幅拉升6.90%。截至发稿，该股报1.55美元/股，成交量2.5753万股，换手率0.09%，振幅0.69%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。其候选产品包括治疗自身免疫性疾病的 CAR-T NXC-201 和治疗软组织肉瘤的 IMX-110。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082139509719ef75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082139509719ef75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2473810598","title":"Immix Biopharma, Inc.盘中异动 股价大涨5.52%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473810598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473810598?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:35","pubTimestamp":1728308124,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时35分，Immix Biopharma, Inc.股票出现波动，股价急速上涨5.52%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Scholar Rock Holding Corporation、Nutriband Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃，换手率分别为579.45%、48.97%、11.82%，振幅较大的相关个股有Scholar Rock Holding Corporation、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Ibio, Inc.，振幅分别为31.81%、18.44%、11.42%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072135249719ea0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072135249719ea0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2472164726","title":"Immix Biopharma, Inc.盘中异动 快速下跌5.48%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472164726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472164726?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:31","pubTimestamp":1727980312,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时31分，Immix Biopharma, Inc.股票出现波动，股价快速跳水5.48%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。其相关个股中，Elevai Labs, Inc.、Theriva Biologics, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为5431.84%、1640.07%、975.16%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为142.28%、63.50%、55.45%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004023153ab679eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004023153ab679eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMMX"],"gpt_icon":0},{"id":"2471338836","title":"Immix Biopharma, Inc.盘中异动 股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471338836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471338836?lang=zh_cn&edition=full","pubTime":"2024-09-30 23:44","pubTimestamp":1727711075,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日23时44分，Immix Biopharma, Inc.股票出现异动，股价快速下跌5.13%。截至发稿，该股报1.48美元/股，成交量7.5076万股，换手率0.27%，振幅4.49%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930234435a1ddb9ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930234435a1ddb9ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0},{"id":"2470275425","title":"Immix Biopharma, Inc.盘中异动 急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470275425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470275425?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:17","pubTimestamp":1727367462,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日00时17分，Immix Biopharma, Inc.股票出现波动，股价急速跳水5.05%。Immix Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Pasithea Therapeutics Corp.、Nucana Plc、Kintara Therapeutics, Inc.较为活跃，换手率分别为4538.34%、160.84%、109.02%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Ocean Biomedical Inc C/Wts 14/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为42.13%、40.81%、40.32%。Immix Biopharma, Inc.公司简介：Immix Biopharma Inc 从事发现和开发治疗血液恶性肿瘤（血癌）和其他适应症的新型细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409270017429719cde4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409270017429719cde4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMMX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immixbio.com","stockEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.2212},{"period":"6month","weight":-0.214},{"period":"1year","weight":-0.6124},{"period":"ytd","weight":-0.7558}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immix Biopharma, Inc.于2014年1月7日成立为特拉华州公司。该公司是一家临床阶段的生物制药公司，在肿瘤学和炎症领域开发一种新型的组织特异性疗法（“TSTx”）TM。该公司的主要资产IMX-110目前正在美国和澳大利亚进行实体瘤的1b/2a期临床试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.057386},{"month":2,"riseRate":0,"avgChangeRate":-0.196349},{"month":3,"riseRate":0,"avgChangeRate":-0.133286},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.121134},{"month":5,"riseRate":0.333333,"avgChangeRate":0.11363},{"month":6,"riseRate":0.666667,"avgChangeRate":0.161675},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.083428},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.078281},{"month":9,"riseRate":0.333333,"avgChangeRate":0.042748},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.044134},{"month":11,"riseRate":1,"avgChangeRate":0.225951},{"month":12,"riseRate":1,"avgChangeRate":0.623385}],"exchange":"NASDAQ","name":"Immix Biopharma, Inc","nameEN":"Immix Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immix Biopharma, Inc,IMMX,Immix Biopharma, Inc股票,Immix Biopharma, Inc股票老虎,Immix Biopharma, Inc股票老虎国际,Immix Biopharma, Inc行情,Immix Biopharma, Inc股票行情,Immix Biopharma, Inc股价,Immix Biopharma, Inc股市,Immix Biopharma, Inc股票价格,Immix Biopharma, Inc股票交易,Immix Biopharma, Inc股票购买,Immix Biopharma, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immix Biopharma, Inc(IMMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immix Biopharma, Inc(IMMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}